Cargando…
A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
BACKGROUND: Human health and life are threatened by cancer with high morbidity and mortality worldwide. In many experiments, CDKN1B level is associated with cancer risk, Nevertheless, no pan-cancer analysis has been conducted on CDKN1B in human cancers. METHODS: With the help of bioinformatics, a pa...
Autores principales: | Huang, Hao, Qiu, Duoliang, Zhou, Zhengyang, Wu, Biaobiao, Shao, Lening, Pu, Yuwei, He, Tengfei, Wu, Yongyou, Cui, Dawei, Zhong, Fengyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335976/ https://www.ncbi.nlm.nih.gov/pubmed/37432583 http://dx.doi.org/10.1007/s12672-023-00746-8 |
Ejemplares similares
-
An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
por: Liu, Xuanyou, et al.
Publicado: (2022) -
Kinase independent oncogenic cyclin D1
por: Casimiro, Mathew C., et al.
Publicado: (2015) -
Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer
por: Howard, David, et al.
Publicado: (2022) -
Basic Pan-Cancer Analysis of the Carcinogenic Effects of Cyclin-Dependent Kinase 4 (CDK4) in Human Surface Tumors
por: Wu, Jingping, et al.
Publicado: (2021) -
MicroRNA-424 serves an anti-oncogenic role by targeting cyclin-dependent kinase 1 in breast cancer cells
por: Xie, Dan, et al.
Publicado: (2018)